# llms.txt for www.northstaronc.com
# Generated on 2025-12-17
# This file indicates which paths are appropriate for LLM access

# ===== ALLOWED PATHS =====
# High-priority content pages recommended for LLM training/access

# High Priority (Documentation, Guides, Core Content)
Allow: /
Allow: /support

# Medium Priority (General Pages)
Allow: /accreditation-and-licensure
Allow: /biopharma-solutions
Allow: /blog-categories/articles
Allow: /blog-categories/case-studies
Allow: /blog-categories/webinars
Allow: /blog-categories/white-papers
Allow: /contact
Allow: /events
Allow: /events/advancements-in-precision-medicine-2023
Allow: /events/biomarkers-in-medicine-seminar-2023
Allow: /events/chronic-disease-management-symposium-2023
Allow: /events/clinical-insights-conference-2023
Allow: /events/clinical-trials-and-ethics-2023
Allow: /events/digital-health-symposium-2023
Allow: /events/future-of-telemedicine-2023
Allow: /events/genomic-medicine-workshop-2023
Allow: /events/health-data-analytics-summit-2023
Allow: /events/healthcare-innovation-forum-2023
Allow: /events/healthcare-policy-and-innovation-2023
Allow: /events/innovations-in-clinical-practice-2023
Allow: /events/patient-engagement-in-research-2023
Allow: /events/personalized-healthcare-summit-2023
Allow: /events/precision-medicine-symposium-2023
Allow: /events/test-webinar-w-landing-page
Allow: /events/unity-event-test-from-northstar
Allow: /insights
Allow: /insights/beyond-hr-how-to-apply-molecular-testing-in-tnbc-her2-and-triple-positive-breast-cancer
Allow: /insights/convenient-complement-to-imaging
Allow: /insights/introducing-northstar-select-a-liquid-biopsy-built-for-clinical-action
Allow: /insights/real-time-molecular-insight
Allow: /insights/the-northstar-note---fall-2025-issue
Allow: /insights/uncovering-more-at-progression
Allow: /insights/what-to-test-and-when-a-molecular-approach-to-advanced-hr-breast-cancer
Allow: /news
Allow: /news/asco24-billiontoone-unveils-results-from-tumour-profiling-test-comparison
Allow: /news/billiontoone-announces-medicare-coverage-for-northstar-select-r
Allow: /news/billiontoone-appoints-dr-gary-palmer-as-chief-medical-officer-oncology-launches-northstar-select-tm-and-northstar-response-tm-liquid-biopsy-assays-for-commercial-use
Allow: /news/billiontoone-launches-oncology-liquid-biopsy-products-for-research-use-announces-clinical-research-collaboration-with-ucsd
Allow: /news/billiontoone-pushing-forward-in-cancer-diagnostics-with-first-data-on-response-monitoring-test
Allow: /news/billiontoones-northstar-response-r-validated-in-new-peer-reviewed-study-building-on-previous-clinical-research
Allow: /news/billiontoones-northstar-select-r-demonstrates-superior-sensitivity-in-prospective-head-to-head-validation-study-publication
Allow: /news/dr-sahin-on-the-utility-of-the-northstar-response-assay-in-gi-cancer
Allow: /news/medicare-covering-billiontoone-northstar-select-cancer-liquid-biopsy-test
Allow: /news/methylation-monitoring-predicts-pan-cancer-outcomes
Allow: /news/the-power-of-one-using-single-molecule-sensitivity-diagnostics-to-fight-cancer
Allow: /news/with-new-validation-data-billiontoone-boosts-commercial-prospects-of-therapy-selection-assay
Allow: /northstar-response
Allow: /northstar-response-new
Allow: /northstar-select
Allow: /northstar-select-new

# ===== DISALLOWED PATHS =====
# Pages that should not be accessed by LLMs

# Excluded (Auth, Admin, Dynamic Content)
Disallow: /category/general-information
Disallow: /category/media-coverage
Disallow: /category/news
Disallow: /category/press-releases
Disallow: /terms-of-use

# Common Exclusions
Disallow: /admin/
Disallow: /login/
Disallow: /auth/
Disallow: /cart/
Disallow: /checkout/
Disallow: /search/
Disallow: /api/

# ===== NOTES =====
# Total pages discovered: 58
# High priority: 2
# Medium priority: 51
# Excluded: 5